Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-05-05, Stock:JNJ, The news for the past five days is as follows:
2021-04-28: NEWS1: Streaming TV, Burritos, Beer, and Capital Gains Taxes.NEWS2: Starbucks CEO: Vaccines and the 'great human reconnection' create a 2- to 3-year tailwind.NEWS3: It’s ‘good to lift’ COVID-19 restrictions right now: UAB Epidemiologist .NEWS4: 3 Top Healthcare Stocks to Buy and Hold for the Next 10 Years.NEWS5: Strong New Drugs Sales to Aid AbbVie's (ABBV) Q1 Earnings.NEWS6: Vaccinated Americans 'can now enjoy some more freedoms,' health expert explains.
2021-04-29: NEWS1: UPDATE 2-Emergent hopes to answer U.S. FDA on Baltimore plant within days.NEWS2: Dr. Krutika Kuppalli explains why COVID-19 cases could get worse in India before improving.NEWS3: Moderna ramps up investments to triple vaccine output, eyes boosters.NEWS4: NYC reopening timeline is a ‘disastrous issue’: Doctor.NEWS5: Doctor: Travel ban from India to the U.S. could be 'counterproductive'.NEWS6: 7 Reasons to Invest in Dividend-Paying Stocks for Retirement.NEWS7: Better Buy: Johnson & Johnson Stock or the Entire S&P 500?.NEWS8: Is Novavax Stock A Buy On Hints Its Covid Vaccine Is Nearing Authorization?.NEWS9: Spain's Reig Jofre new plant to produce J&J vaccine by end-Q2.
2021-04-30: NEWS1: 'Things are going to get much worse before they get better' in India: Expert.NEWS2: West Virginia Governor on offering incentives after state ‘hit a wall’ in vaccinations.NEWS3: Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: Bloomberg.NEWS4: West Virginia city takes big three drug distributors to court over opioids.NEWS5: California has lowest COVID-19 case rate in the U.S.: RPT.NEWS6: Pharma Stock Roundup: Big Drugmakers' Q1 Earnings, Resumption of JNJ US COVID-19 Jabs.NEWS7: Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days.NEWS8: South Africa regulator says J&J shot can be given to pregnant women.NEWS9: Emergent (EBS) Beats on Q1 Earnings, Cuts Contract Revenue View.
2021-05-03: NEWS1: AbbVie's Humira Still Number 1 in Drug Sales.NEWS2: Vaccine Hesitancy Ticks Down — Here's What That Means For Covid Stocks.NEWS3: A ‘one size fits all policy’ for reopening travel is very concerning: Doctor.NEWS4: Denmark says it won't use J&J COVID vaccine due to blood-clotting concerns.NEWS5: People should focus on wearing masks indoors 'where it matters the most': Doctor.NEWS6: COVID-19 latest: U.S. cases fall, EU looks to reopen, India cases on the rise.NEWS7: UPDATE 2-Denmark ditches J&J COVID-19 shots from vaccination programme.NEWS8: UPDATE 4-Big three drug distributors blame doctors, regulators in trial over opioid epidemic.NEWS9: 3 Big Drugmaker Stocks to Watch Out For Amid Pandemic Woes.NEWS10: Eupraxia Pharmaceuticals Inc. Announces Appointment of Bruce Cousins as President & CFO.NEWS11: The Zacks Analyst Blog Highlights: Eli Lilly, Merck, GlaxoSmithKline, Novartis and Johnson & Johnson.NEWS12: Drug distributors face off against West Virginia in billion-dollar opioid trial.NEWS13: Denmark drops J&J Covid vaccine over blood clot concerns.
2021-05-04: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: Why Emergent BioSolutions Stock Dropped 30% in April.NEWS3: Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus.NEWS4: Pfizer in talks with India for COVID-19 vaccine.NEWS5: How businesses are tracking their employee's vaccination status and well-being amid COVID-19 recovery.NEWS6: 'We’re entering the harder phase' of coronavirus vaccination.NEWS7: Biden aims to have 70% of U.S. adults receive first vaccine shot by July 4th.NEWS8: Returning to normal ‘doesn’t have to be the goal’ amid COVID-19 recovery: Doctor.NEWS9: Zacks Industry Outlook Highlights: Johnson & Johnson, AstraZeneca and Pfizer.NEWS10: Could Tonix Pharmaceuticals Be a Millionaire-Maker Stock?.NEWS11: Is Emergent BioSolutions Still a Buy After Its Coronavirus Vaccine Flub?.NEWS12: The Big Winner for Johnson & Johnson in Q1.NEWS13: Travel stocks rally as EU prepares to open borders to vaccinated holidaymakers.

Answer: Decrease